Ivax Product Failure Tracking System Inadequate - FDA Warning Letter
Ivax' product failure tracking system is inadequate, an FDA warning letter to the company states.
You may also be interested in...
Ivax' quality unit failed to investigate eight complaints of discoloration for perphenazine tablets, FDA said in a warning letter.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011